References
- Bruder M, Haseler PL, Muscarella M, Lewis W, Moody CJ. 2010. Synthesis of the oxepinochromone natural products ptaeroxylin (desoxykarenin), ptaeroxylinol, and eranthin. J Org Chem. 75:353–358.
- Darlington GJ, Ross SE, MacDougald OA. 1998. The role of C/EBP genes in adipocyte differentiation. J Biol Chem. 273:30057–30060.
- Farmer SR. 2005. Regulation of PPAR gamma activity during adipogenesis. Int J Obes. 29:S13–S16.
- Hung TY, Chen TL, Liao MH, Ho WP, Liu DZ, Chuang WC, Chen RM. 2010. Drynaria fortunei J. Sm. promotes osteoblast maturation by inducing differentiation-related gene expression and protecting against oxidative stress-induced apoptotic insults. J Ethnopharmacol. 131:70–77.
- Kim SB, Ahn JH, Han SB, Hwang BY, Kim SY, Lee MK. 2012. Anti-adipogenic chromone glycosides from Cnidium monnieri fruits in 3T3-L1 cells. Bioorg Med Chem Lett. 22:6267–6271.
- Kuo HC, Chang HC, Lan WC, Tsai FH, Liao JC, Wu CR. 2014. Protective effects of Drynaria fortunei against 6-hydroxydopamine-induced oxidative damage in B35 cells via the PI3K/AKT pathway. Food Funct. 5:1956–1965.
- Liang YH, Wang W, Yu SW, Ye M, He XH, Gong NB, Lu Y, Khan IA, Guo DA. 2010. A new chiratane type triterpenoid from the rhizomes of Drynaria fortunei. Fitoterapia. 81:988–991.
- Liang YH, Ye M, Yang WZ, Qiao X, Wang Q, Yang HJ, Wang XL, Guo DA. 2011. Flavan-3-ols from the rhizomes of Drynaria fortunei. Phytochemistry. 72:1876–1882.
- Qiao X, Lin XH, Liang YH, Dong J, Guo DA, Ye M. 2014. Comprehensive chemical analysis of the rhizomes of Drynaria fortunei by orthogonal pre-separation and liquid chromatography mass spectrometry. Planta Med. 80:330–336.
- Rosen ED, Hsu CH, Wang XZ, Sakai S, Freeman MW, Gonzalez FJ, Spiegelman BM. 2002. C/EBP alpha induces adipogenesis through PPAR gamma: a unified pathway. Genes Dev. 16:22–26.
- Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM. 1999. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 4:611–617.
- Shang ZP, Meng JJ, Zhao QC, Su MZ, Luo Z, Yang L, Tan JJ. 2013. Two new chromone glycosides from Drynaria fortunei. Fitoterapia. 84:130–134.
- Shaughnessy S, Smith ER, Kodukula S, Storch J, Fried SK. 2000. Adipocyte metabolism in adipocyte fatty acid binding protein knockout (aP2(–/–)) mice after short-term high-fat feeding – functional compensation by the keritinocyte fatty acid binding protein. Diabetes. 49:904–911.
- Tane P, Ayafor JF, Sondengam BL, Connolly JD. 1990. Chromone glycosides from Schumanniophyton magnificum. Phytochemistry. 29:1004–1007.
- Waki H, Tontonoz P. 2007. Endocrine functions of adipose tissue. Annu Rev Pathol Mech Dis. 2:31–56.
- Wang JN, Jiang JJ, Xie YM, Wei X, Li JP, Duan JL, Xiong X. 2012. Population pharmacokinetics of naringin in total flavonoids of Drynaria fortunei (Kunze) J. Sm. in Chinese women with primary osteoporosis. Chin J Integr Med. 18:925–933.
- Wang XL, Wang NL, Gao H, Zhang G, Qin L, Wong MS, Yao XS. 2010. Phenylpropanoid and flavonoids from osteoprotective fraction of Drynaria fortunei. Nat Prod Res. 24:1206–1213.
- Wang XL, Zhen LZ, Zhang G, Wong MS, Qin L, Yao XS. 2011. Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei – an in vitro efficacy study. Phytomedicine. 18:868–872.
- Wong KC, Pang WY, Wang XL, Mok SK, Lai WP, Chow HK, Leung PC, Yao XS, Wong MS. 2013. Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone. Br J Nutr. 110:475–485.
- Yoshimitsu H, Nishida M, Hashimoto F, Tanaka M, Sakata Y, Okawa M, Nohara T. 2007. Chromone and flavonol glycosides from Delphinium hybridum cv. ‘Belladonna Casablanca’. J Nat Med. 61:334–338.
- Zhang Y, Wu CH, Guo LL, Chen Y, Han LF, Liu EW, Gao XM, Wang T. 2013. Triglyceride accumulation inhibitory effects of phenylpropanoid glycosides from Boschniakia rossica Fedtsch et Flerov. Fitoterapia. 85:69–75.